Brief: Vaxil Provides Update On In Vivo Study
Aug 27 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL PROVIDES UPDATE ON IN VIVO STUDY
* VAXIL BIO LTD - OVER LAST FEW WEEKS, CORVAX INJECTIONS
WERE
ADMINISTERED AND ARE NOW COMPLETE
* VAXIL BIO LTD - NOW PROCEEDING TO EVALUATE RESULTS AND
EXPECTS
TO COMPLETE THIS PROCESS INCLUDING ANALYSES DURING NEXT 4 TO 6
WEEKS
Source text for Eikon: ID:nGNX5QtGPc
Further company coverage: VXL.V
((Reuters.briefs@thomsonreuters.com;))
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover